Literature DB >> 12029050

Substrate recognition properties of oligopeptidase B from Salmonella enterica serovar Typhimurium.

Rory E Morty1, Vilmos Fülöp, Norma W Andrews.   

Abstract

Oligopeptidase B (OpdB) is a serine peptidase broadly distributed among unicellular eukaryotes, gram-negative bacteria, and spirochetes which has emerged as an important virulence factor and potential therapeutic target in infectious diseases. We report here the cloning and expression of the opdB homologue from Salmonella enterica serovar Typhimurium and demonstrate that it exhibits amidolytic activity exclusively against substrates with basic residues in P(1). While similar to its eukaryotic homologues in terms of substrate specificity, Salmonella OpdB differs significantly in catalytic power and inhibition and activation properties. In addition to oligopeptide substrates, restricted proteolysis of histone proteins was observed, although no cleavage was seen at or near residues that had been posttranslationally modified or at defined secondary structures. This supports the idea that the catalytic site of OpdB may be accessible only to unstructured oligopeptides, similar to the closely related prolyl oligopeptidase (POP). Salmonella OpdB was employed as a model enzyme to define determinants of substrate specificity that distinguish OpdB from POP, which hydrolyzes substrates exclusively at proline residues. Using site-directed mutagenesis, nine acidic residues that are conserved in OpdBs but absent from POPs were converted to their corresponding residues in POP. In this manner, we identified a pair of glutamic acid residues, Glu(576) and Glu(578), that define P(1) specificity and direct OpdB cleavage C terminal to basic residues. We have also identified a second pair of residues, Asp(460) and Asp(462), that may be involved in defining P(2) specificity and thus direct preferential cleavage by OpdB after pairs of basic residues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029050      PMCID: PMC135088          DOI: 10.1128/JB.184.12.3329-3337.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  38 in total

1.  Oligopeptidase B: a new type of serine peptidase with a unique substrate-dependent temperature sensitivity.

Authors:  L Polgár
Journal:  Biochemistry       Date:  1999-11-23       Impact factor: 3.162

2.  Catalysis of serine oligopeptidases is controlled by a gating filter mechanism.

Authors:  V Fülöp; Z Szeltner; L Polgár
Journal:  EMBO Rep       Date:  2000-09       Impact factor: 8.807

3.  The use of CLUSTAL W and CLUSTAL X for multiple sequence alignment.

Authors:  A Aiyar
Journal:  Methods Mol Biol       Date:  2000

4.  Involvement of cytosolic prolyl endopeptidase in degradation of p40-phox splice variant protein in myeloid cells.

Authors:  T Hasebe; J Hua; A Someya; P Morain; F Checler; I Nagaoka
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

5.  Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters.

Authors:  R E Morty; L Troeberg; J C Powers; S Ono; J D Lonsdale-Eccles; T H Coetzer
Journal:  Biochem Pharmacol       Date:  2000-11-15       Impact factor: 5.858

6.  Construction of a 3D model of oligopeptidase B, a potential processing enzyme in prokaryotes.

Authors:  T Gérczei; G M Keserü; G Náray-Szabó
Journal:  J Mol Graph Model       Date:  2000-02       Impact factor: 2.518

7.  The opdB locus encodes the trypsin-like peptidase activity of Treponema denticola.

Authors:  J C Fenno; S Y Lee; C H Bayer; Y Ning
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity.

Authors:  R E Morty; J D Lonsdale-Eccles; R Mentele; E A Auerswald; T H Coetzer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

9.  Complete genome sequence of Salmonella enterica serovar Typhimurium LT2.

Authors:  M McClelland; K E Sanderson; J Spieth; S W Clifton; P Latreille; L Courtney; S Porwollik; J Ali; M Dante; F Du; S Hou; D Layman; S Leonard; C Nguyen; K Scott; A Holmes; N Grewal; E Mulvaney; E Ryan; H Sun; L Florea; W Miller; T Stoneking; M Nhan; R Waterston; R K Wilson
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

10.  Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue.

Authors:  V Fülöp; Z Szeltner; V Renner; L Polgár
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

View more
  13 in total

1.  Structure and catalysis of acylaminoacyl peptidase: closed and open subunits of a dimer oligopeptidase.

Authors:  Veronika Harmat; Klarissza Domokos; Dóra K Menyhárd; Anna Palló; Zoltán Szeltner; Ilona Szamosi; Tamás Beke-Somfai; Gábor Náray-Szabó; László Polgár
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

2.  A typhus group-specific protease defies reductive evolution in rickettsiae.

Authors:  Nicole C Ammerman; Joseph J Gillespie; Andrew F Neuwald; Bruno W Sobral; Abdu F Azad
Journal:  J Bacteriol       Date:  2009-10-09       Impact factor: 3.490

3.  Oligopeptidase B deficient mutants of Leishmania major.

Authors:  Jane C Munday; Karen McLuskey; Elaine Brown; Graham H Coombs; Jeremy C Mottram
Journal:  Mol Biochem Parasitol       Date:  2010-09-29       Impact factor: 1.759

4.  Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells.

Authors:  Izabela M D Bastos; Philippe Grellier; Natalia F Martins; Gloria Cadavid-Restrepo; Marian R de Souza-Ault; Koen Augustyns; Antonio R L Teixeira; Joseph Schrével; Bernard Maigret; José F da Silveira; Jaime M Santana
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

5.  Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2-dependent cross talk mechanisms modulate extracellular proteolytic activities.

Authors:  Theodor Chitlaru; Orit Gat; Yael Gozlan; Naomi Ariel; Avigdor Shafferman
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

6.  Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome.

Authors:  Jaak Jaeken; Kevin Martens; Inge Francois; Francois Eyskens; Claudine Lecointre; Rita Derua; Sandra Meulemans; Jerry W Slootstra; Etienne Waelkens; Francis de Zegher; John W M Creemers; Gert Matthijs
Journal:  Am J Hum Genet       Date:  2005-11-23       Impact factor: 11.025

7.  Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity.

Authors:  Jefferson P Hemerly; Vitor Oliveira; Elaine Del Nery; Rory E Morty; Norma W Andrews; Maria A Juliano; Luiz Juliano
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

8.  Oligopeptidase B from Leishmania amazonensis: molecular cloning, gene expression analysis and molecular model.

Authors:  Herbert Leonel de Matos Guedes; Monique Pacheco Duarte Carneiro; Daniel Cláudio de Oliveira Gomes; Bartira Rossi-Bergmann; Salvatore Giovanni De-Simone
Journal:  Parasitol Res       Date:  2007-09       Impact factor: 2.289

9.  Oligopeptidase B from L. amazonensis: molecular cloning, gene expression analysis and molecular model.

Authors:  Herbert Leonel de Matos Guedes; Monique Pacheco Duarte Carneiro; Daniel Cláudio de Oliveira Gomes; Bartira Rossi-Bergmanmn; Salvatore Giovanni de Simone
Journal:  Parasitol Res       Date:  2007-05-27       Impact factor: 2.289

10.  Crystal structure of Leishmania major oligopeptidase B gives insight into the enzymatic properties of a trypanosomatid virulence factor.

Authors:  Karen McLuskey; Neil G Paterson; Nicholas D Bland; Neil W Isaacs; Jeremy C Mottram
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.